{"organizations": [], "uuid": "1dd6c0d786f166846ae298553f5e2786a1544fb0", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180308.html", "section_title": "Archive News &amp; Video for Thursday, 08 Mar 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-oncomed-q4-earnings-per-share-025/brief-oncomed-q4-earnings-per-share-0-25-idUSASB0C9KW", "country": "US", "domain_rank": 408, "title": "BRIEF-OncoMed Q4 Earnings Per Share $0.25", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.964, "site_type": "news", "published": "2018-03-09T05:32:00.000+02:00", "replies_count": 0, "uuid": "1dd6c0d786f166846ae298553f5e2786a1544fb0"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-oncomed-q4-earnings-per-share-025/brief-oncomed-q4-earnings-per-share-0-25-idUSASB0C9KW", "ord_in_thread": 0, "title": "BRIEF-OncoMed Q4 Earnings Per Share $0.25", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "oncomed pharmaceuticals inc", "sentiment": "negative"}, {"name": "thomson reuters trust principles", "sentiment": "none"}, {"name": "thomson reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 8 (Reuters) - OncoMed Pharmaceuticals Inc:\n* ONCOMED ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS\n* Q4 REVENUE $20.6 MILLION VERSUS $6.2 MILLION * CURRENT CASH IS ESTIMATED TO BE SUFFICIENT TO FUND OPERATIONS THROUGH AT LEAST Q3 OF 2019\n* Q4 EARNINGS PER SHARE VIEW $-0.33, REVENUE VIEW $5.2 MILLION â€” THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:\nOur Standards: The Thomson Reuters Trust Principles.", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-03-09T05:32:00.000+02:00", "crawled": "2018-03-09T14:21:44.002+02:00", "highlightTitle": ""}